[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.136.184. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

August 2019 - April 2016

Decade

Year

Issue

May 2017, Vol 2, No. 5, Pages 465-582

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):465. doi:10.1001/jamacardio.2016.3644
Original Investigation

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study

Abstract Full Text
free access has audio
JAMA Cardiol. 2017;2(5):478-487. doi:10.1001/jamacardio.2017.0063

This randomized clinical trial assesses the prognosis of cardiovascular and bleeding events occurring beyond 1 year after coronary stenting.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial

Abstract Full Text
open access
JAMA Cardiol. 2017;2(5):490-497. doi:10.1001/jamacardio.2017.0022

This multicenter, randomized clinical trial investigates whether ischemic postconditioning of the infarct-related artery vs conventional percutaneous coronary intervention can improve the clinical outcomes of patients with acute onset of ST-segment elevation myocardial infarction.

A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: The Tamil Nadu–ST-Segment Elevation Myocardial Infarction Program

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):498-505. doi:10.1001/jamacardio.2016.5977

This multicenter study examines access to reperfusion and percutaneous coronary intervention during ST-segment elevation myocardial infarction in Indian clinics and hospitals using a hub-and-spoke model.

Bystander Defibrillation for Out-of-Hospital Cardiac Arrest in Public vs Residential Locations

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):507-514. doi:10.1001/jamacardio.2017.0008

This nationwide cohort study examined changes in bystander defibrillation and subsequent survival among patients with out-of-hospital cardiac arrest according to public or residential location.

Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):516-523. doi:10.1001/jamacardio.2017.0064

This population-based cohort study evaluates the presence of inflammation markers in individuals with atrial fibrillation over a 20-year follow-up.

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):525-534. doi:10.1001/jamacardio.2017.0065

This patient-level analysis of the ARISTOTLE randomized clinical trial assesses the cost and cost-effectiveness of apixaban therapy compared with warfarin therapy in patients with atrial fibrillation from the perspective of the US health care system.

Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):536-546. doi:10.1001/jamacardio.2017.0264

This cohort study investigates whether HIV infection increased the risk of future heart failure with reduced ejection fraction and heart failure with preserved ejection fraction in the Veterans Aging Cohort Study.

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):547-555. doi:10.1001/jamacardio.2017.0083

This prespecified analysis assesses the safety and clinical efficacy of achieving a very low (<30 mg/dL) level of low-density lipoprotein cholesterol at 1 month in patients with acute coronary syndrome using data from the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.

Brief Report

Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):556-560. doi:10.1001/jamacardio.2016.5395

This study of pooled data from patients in 4 randomized clinical trials characterizes variability in proprotein convertase subtilisin kexin type 9 (PCSK9) levels and determines whether the reduction in low-density lipoprotein cholesterol level achieved with evolocumab differs based on PCSK9 levels.

Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):561-565. doi:10.1001/jamacardio.2016.5388

This cohort study identifies patient, clinician, and hospital characteristics associated with cardiac resynchronization therapy defibrillator use and determine the extent of hospital-level variation in this use among guideline-eligible patients undergoing implantable cardioverter defibrillator placement.

Research Letter

Value of Cardiovascular Magnetic Resonance Imaging–Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):577-579. doi:10.1001/jamacardio.2016.5492

This study tests the hypothesis that cardiovascular magnetic resonance–derived left ventricular ejection fraction and volumes would provide improved risk stratification in patients undergoing coronary artery bypass surgery for ischemic cardiomyopathy.

Viewpoint

Reconfiguring the Hospital-to-Home Transition Into an Active Treatment Period for Patients With Heart Failure

Abstract Full Text
JAMA Cardiol. 2017;2(5):467-468. doi:10.1001/jamacardio.2017.0084

This Viewpoint argues for a reconfiguration of the transition phase between hospital and home by extending active treatment beyond the acute care setting.

Cardiopulmonary Resuscitation Training in China: Current Situation and Future Development

Abstract Full Text
JAMA Cardiol. 2017;2(5):469-470. doi:10.1001/jamacardio.2017.0035

This Viewpoint discusses recent efforts to improve the low rates and quality of cardiopulmonary resuscitation (CPR) by bystanders in China via CPR training.

From the Heart

A Vocation, for Love of a Mentor

Abstract Full Text
JAMA Cardiol. 2017;2(5):471-472. doi:10.1001/jamacardio.2016.5904
Editorial

JAMA Cardiology Inaugural Year in Review

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):473-474. doi:10.1001/jamacardio.2017.0381

Proteomics of Atrial Fibrillation: Evolving From a Coarse Understanding to a Fine Phenotype

Abstract Full Text
JAMA Cardiol. 2017;2(5):474-475. doi:10.1001/jamacardio.2017.0292

Heart Failure With Reduced Ejection Fraction in Human Immunodeficiency Virus Infection: The More Things Stay the Same

Abstract Full Text
JAMA Cardiol. 2017;2(5):476-477. doi:10.1001/jamacardio.2017.0282
Invited Commentary

Deciding on the Duration of Dual Antiplatelet Therapy—When the Choice Between 2 Evils Is Still Evil

Abstract Full Text
JAMA Cardiol. 2017;2(5):488-489. doi:10.1001/jamacardio.2017.0125

Quality Improvement in Cardiac Services in India: Quo Vadis?

Abstract Full Text
JAMA Cardiol. 2017;2(5):505-506. doi:10.1001/jamacardio.2016.6008

Cardiac Arrest in Any Location: The Need for Fewer Bystanders and More Layperson Rescuers

Abstract Full Text
JAMA Cardiol. 2017;2(5):514-515. doi:10.1001/jamacardio.2017.0040

Are Novel Anticoagulants Worth Their Cost?

Abstract Full Text
JAMA Cardiol. 2017;2(5):534-535. doi:10.1001/jamacardio.2017.0126
Review

Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(5):566-574. doi:10.1001/jamacardio.2017.0364

This review examines the historical basis for anticoagulant monitoring, discusses methods to measure and interpret drug levels, and critically assesses the role of routine laboratory monitoring in the management of non–vitamin K antagonist oral anticoagulant therapy.

JAMA Cardiology Clinical Challenge

Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(5):575-576. doi:10.1001/jamacardio.2017.0263

A 30-year-old woman diagnosed with primary sclerosing cholangitis during pregnancy 5 years earlier was referred with severe hypercholesterolemia. She first noted the appearance of periorbital xanthelasmata 2 years after diagnosis of primary sclerosis cholangitis and developed marked worsening of biliary obstruction, deterioration of liver function, and clinical jaundice 6 months prior to referral. What would you do next?

Comment & Response

Coronary Angiography and Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest

Abstract Full Text
JAMA Cardiol. 2017;2(5):580. doi:10.1001/jamacardio.2016.5785

Coronary Angiography and Percutaneous Coronary Intervention After Out-of-Hospital Cardiac Arrest—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(5):580-581. doi:10.1001/jamacardio.2016.5788

Cost-effectiveness of Intensive Blood Pressure Management—Is There an Additional Price to Pay?

Abstract Full Text
JAMA Cardiol. 2017;2(5):581. doi:10.1001/jamacardio.2016.5834

Cost-effectiveness of Intensive Blood Pressure Management—Is There an Additional Price to Pay?—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(5):581-582. doi:10.1001/jamacardio.2016.5837
Editor's Note

How We Evaluate Biomarker Studies

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):524. doi:10.1001/jamacardio.2017.0291
Peer Reviewers List

JAMA Cardiology List of Peer Reviewers

Abstract Full Text
free access online only
JAMA Cardiol. 2017;2(5):e170284. doi:10.1001/jamacardio.2017.0284
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(5):466. doi:10.1001/jamacardio.2016.3645
×